Celebrating Oncology Nursing: United to lead through Adversity
Global Power of Oncology Nursing
Menu
GPON 2023 Programme
07:00 UTC – 11:00 UTC in English
UK TIME
Topic
Speaker
07:00–07:10
Welcome from GPON Steering Group
Annie Young, U.K.
07:10–07:20
Welcome Address from WHO Chief Nurse
Dr Amelia Latu Afuhaamango Tuipulotu
07.20–08.15
Oncology Nursing in Troubled Zones
Chair: Dilnasheen Safdar
Dr Ishraga Madan, Sudan
Hatice Burgac, Turkey
Muhammad Ali, Pakistan
Sinem Kılınç, Turkey
08:15–08:30
Break
08:30–09:15
Nurse migration
Chair: Vera Samba
Mavis Bobie Ansah, Ghana
Emma Treanor, U.K.
Joseph Duenas, U.K.
Latoya Silvera, Jamaica
09:15–09:30
Nurse Research Highlight from LMIC:
Nursing Older People with Cancer in Rural and Urban China
Chair: Gulcan Bagcivan
Meiya Lai, China
09:30–09:40
Break
09:40–10:20
Inspirational Stories
Lebanese survivor studying nursing
10 years post-transplant nurse researcher
Chair: Barry Quinn
Lynn Hamzeh, Lebanon
Sumaira Sharif, Pakistan
10.20–10.30
United to Lead through Adversity
Vera Samba and Team, Cameroon
10.30–10:55
Round up, Awards and Thank you
Julia Downing, U.K. and Uganda
20:00 UTC – 22:30 UTC bilingual in English and Spanish with simultaneous translation
20.00–20:10
Welcome
Julia Challinor, U.S.A.
20.10–20:20
Welcome Address from WHO Chief Nurse
Dr Amelia Latu Afuhaamango Tuipulotu
20:20–21:00
Nurse Migration: Lived experience
Chair: Lucia Robles
Andreas Martin Guse, Germany
Carolina Monjaras Guerra, Mexico
Dalia Elizabeth Galicia Pineda, Mexico
Aranis Ariadne González Durán, Mexico
21:00–21:20
Climate change and oncology nursing on the frontline
Chair: Julia Challinor
Ruby Gidda, Canada
Joy Bunsko, Canada
21:20–21:50
Effect of the nursing consultancy model on quality of life and toxicity caused by chemotherapy in patients with cancer
Efecto del modelo de consultoría de enfermería en la calidad de vida y toxicidad causada por quimioterapia en pacientes con cáncer
Chair: Julia Challinor
María Nidia Mercado Martínez, Mexico
21:50–22:20
Inspirational Speaker:
How the nurse interacts with the patients
Chair: Julia Challinor
Carolyn Taylor, USA
22:20–22:30
Closing Remarks
Myrna Doumit, Lebanon
Event Partner
Event Partner
Event Partner
Event Partner
Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.
Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, USA, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the US, Europe and Japan.
Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity.
The commitment of our talented team of world-class scientists to continued scientific excellence has enabled us to identify new molecules, decipher new pathways and develop first-in-class and best-in-class medicines.
LEO Pharma
LEO Pharma is a leader in thrombosis with a specific focus on cancer associated thrombosis. We have worked with healthcare professionals to care for people with thrombosis for over 80 years. We strive to improve lives with high ethics and holistic support, setting new standards of care.
LEO Pharma headquarters are in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries. For more information please visit: